Be precise! The need to consider the mechanisms for CEP17 copy number changes in breast cancer
Author:
Publisher
Wiley
Subject
Pathology and Forensic Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.2593/fullpdf
Reference13 articles.
1. Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations;Sauter;J Clin Oncol,2009
2. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer;Wolff;J Clin Oncol,2007
3. The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study;Downs-Kelly;Am J Surg Pathol,2005
4. Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing;Vanden Bempt;J Clin Oncol,2008
5. Herceptin Adjuvant (HERA) Trial Study Team: trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;Piccart-Gebhart;N Engl J Med,2005
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 8p11.23 Amplification in Breast Cancer: Molecular Characteristics, Prognosis and Targeted Therapy;Journal of Clinical Medicine;2020-09-24
2. New Insights to Reshape the Management of Patients with Metastatic Breast Cancer - Focus on Overcoming Challenges in HER2 Status Interpretation;The Open Biomarkers Journal;2020-06-04
3. Amplification of Chromosome 17 Centromere (CEP17) in Breast Cancer Patients with a Result of HER2 2± by Immunohistochemistry;Cancer Investigation;2020-01-29
4. Chromosome 17 centromere amplification and chromosomal instability (CIN) in breast cancer: Pathogenic and therapeutic implications;Neoplasma;2019
5. Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification;Breast Cancer Research and Treatment;2018-03-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3